- Home
- EWTX vs KBR Comparison
EWTX vs KBR Comparison
Compare EWTX & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWTX | KBR |
|---|---|---|
| Founded | 2017 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.2B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | EWTX | KBR |
|---|---|---|
| Price | $34.09 | $35.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $39.00 | ★ $52.43 |
| AVG Volume (30 Days) | 1.3M | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.83% |
| EPS Growth | N/A | ★ 15.05 |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $5,767,000,000.00 |
| Revenue This Year | N/A | $4.56 |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | ★ N/A | $42.94 |
| Revenue Growth | N/A | ★ 2.27 |
| 52 Week Low | $12.31 | $29.94 |
| 52 Week High | $40.77 | $54.38 |
Technical Indicators
Market Signals| Indicator | EWTX | KBR |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 53.31 |
| Support Level | $28.27 | $29.94 |
| Resistance Level | $35.00 | $39.03 |
| Average True Range (ATR) | 2.20 | 1.23 |
| MACD | -0.22 | 0.21 |
| Stochastic Oscillator | 29.32 | 65.61 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.
About KBR KBR Inc.
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.